Inogen (NASDAQ:INGN – Get Free Report) is projected to issue its quarterly earnings data after the market closes on Tuesday, February 25th. Analysts expect the company to announce earnings of ($0.56) per share and revenue of $73.90 million for the quarter. Investors interested in participating in the company’s conference call can do so using this link.
Inogen Stock Performance
Shares of INGN stock opened at $9.91 on Friday. The stock has a market capitalization of $236.06 million, a P/E ratio of -4.40 and a beta of 1.02. The company has a 50 day moving average price of $10.17 and a 200 day moving average price of $10.30. Inogen has a fifty-two week low of $5.82 and a fifty-two week high of $13.33.
Analyst Upgrades and Downgrades
Several research analysts have recently issued reports on INGN shares. StockNews.com upgraded shares of Inogen from a “hold” rating to a “buy” rating in a report on Monday, February 10th. Needham & Company LLC restated a “hold” rating on shares of Inogen in a report on Thursday, January 30th.
Inogen Company Profile
Inogen, Inc, a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.
See Also
- Five stocks we like better than Inogen
- 5 Top Rated Dividend Stocks to Consider
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- The How and Why of Investing in Gold Stocks
- DuPont’s Electronics Spinoff: The Start of Something Big
- What Does a Stock Split Mean?
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for Inogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inogen and related companies with MarketBeat.com's FREE daily email newsletter.
